This resolution acknowledges the significant harm caused by diethylstilbestrol (DES) , a drug widely prescribed to pregnant women until 1971, which resulted in severe health complications, including rare cancers and fertility issues, for children exposed in utero. It expresses support for designating a "DES Awareness Week" to highlight the drug's history and impact, and advocates for the restoration of funding for the DES Follow-Up Study , which tracks the long-term health effects on affected individuals. Furthermore, the resolution urges the Food and Drug Administration (FDA) to issue a formal apology to the families impacted by the prolonged use of DES, recognizing the agency's role in its approval and subsequent harm.